EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $601,000 | +8485.7% | 10,000 | +7252.9% | 0.02% | – |
| Q1 2019 | $7,000 | -41.7% | 136 | -52.9% | 0.00% | -100.0% |
| Q4 2018 | $12,000 | +33.3% | 289 | +112.5% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -96.5% | 136 | -96.0% | 0.00% | -93.8% |
| Q2 2018 | $258,000 | +41.8% | 3,407 | 0.0% | 0.02% | +6.7% |
| Q4 2017 | $182,000 | -24.2% | 3,407 | -15.2% | 0.02% | -31.8% |
| Q3 2017 | $240,000 | +15.9% | 4,018 | +53.5% | 0.02% | +10.0% |
| Q2 2017 | $207,000 | -20.1% | 2,618 | -19.7% | 0.02% | -35.5% |
| Q4 2016 | $259,000 | +66.0% | 3,260 | +46.2% | 0.03% | +93.8% |
| Q3 2016 | $156,000 | +15500.0% | 2,230 | +2130.0% | 0.02% | – |
| Q3 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |